An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

Agitation is one of the most distressing symptoms of Alzheimer's dementia, and we are pleased to make positive strides forward in treatment of these patients." Paul Rosenberg, M.D., professor of ...

Dementia is the biggest health challenge facing the UK ... In some people, though, they make no difference and cause side effects such as confusion and agitation.” Medication not specifically for ...

"It is the agitation, not the memory loss, that often drives individuals with dementia to the emergency ... needed to better understand predictors of treatment response to help inform subsequent ...

MONDAY, Sept. 30, 2024 (HealthDay News) -- A synthetic form of the active ingredient in cannabis helps reduce agitation in ...